Ladiasan, Engcang .
HRN: 26-96-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
CEFUROXIME 1.5GM (VIAL)
04/10/2025
04/17/2025
IV
1.5 Gram
Q8h
UTI
Waiting Final Action